GENE ONLINE|News &
Opinion
Blog

2025-03-03|

Immune Cells Exhibit Dual Functional Roles in Defense and Attack

by Mark Chiang
Share To
IBM's top executives discussed AI's role in hybrid cloud solutions and the crucial steps businesses must take to achieve meaningful outcomes. Image: Shutterstock

Researchers at Ludwig Maximilian University (LMU) have uncovered groundbreaking insights into the flexibility of dendritic cells, a key component of the body’s innate immune system. Traditionally recognized for their role in defending against infections, these cells are now understood to possess dual functionalities that could pave the way for innovative therapeutic strategies.

Dendritic cells are primarily known for their ability to detect pathogens and orchestrate an appropriate immune response. This recent study by LMU researchers reveals that these cells are not limited to defensive actions but are also capable of transitioning into an attack mode under certain conditions.

This newfound understanding of dendritic cell versatility enhances the potential for developing new treatments that could manipulate these cells to fight various diseases more effectively. The implications of this research extend beyond traditional approaches, offering hope for more targeted and efficient therapies.

Date: February 28, 2025

Newsflash | Powered by GeneOnline AI

 

©www.geneonline.com All rights reserved. Collaborate with us: [email protected]
Related Post
Study Finds Semisynthetic Bile Acid Reduces Pro-Inflammatory Cells in Gut
2025-03-14
Study Identifies Epstein-Barr Virus Antibodies Linked to Multiple Sclerosis Development
2025-03-12
Breakthrough in Cancer Vaccine Development Enhances Effectiveness and Reach
2025-03-03
LATEST
AI’s Promise to Profits: How IBM is Maximizing Business ROI with Accelerated Computing
2025-03-19
Edge Computing: The Next Big Thing in AI and Automation
2025-03-19
Neurosurgery Now: NVIDIA’s Holoscan AI Brings Real-Time 3D Vision to Enhance Surgical Precision at 2025 GTC
2025-03-18
NVIDIA GTC 2025: BioMap’s xTrimo — The AI Model That’s Changing Biotech and Drug Discovery
2025-03-18
AstraZeneca Acquires Cell Therapy Company in $1 Billion Deal to Develop In Vivo Cancer Treatments
2025-03-18
Gene Therapy Achieves Complete Cure for Sickle Cell Anemia in New York Patient
2025-03-17
NICE Recommends New Endometriosis Treatment for NHS Patients
2025-03-14
EVENT
2025-03-17
BIO-Europe Spring 2025
Milan, Italy
2025-04-21
World Vaccine Congress Washington 2025
Washington, U.S.A
2025-04-21
World Vaccine Congress 2025
Washington, U.S.A
2025-04-25
AACR Annual Meeting 2025
Chicago, U.S.A
2025-04-26
SABPA OC/LA 17th Annual Biomedical Forum
Irvine, California, United States
Scroll to Top